Identification of a new P-glycoprotein-like ATP-binding cassette transporter gene that is overexpressed during hepatocarcinogenesis

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3708-3716

  Furuya, Katryn N ^a,b,d   Bradley, Grace ^c   Sun, Daxi ^a   Schuetz, Erin G ^a   Schuetz, John D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CYTOTOXIN; GLYCOPROTEIN P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOTOXICITY; DNA LIBRARY; LIVER CARCINOGENESIS; MALIGNANT TRANSFORMATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SOUTHERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; HYPERPLASIA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM PROTEINS; OPEN READING FRAMES; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0030880937     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Sang, J., Lim, Y., Panzica, M., Finch, P., and Thompson, N. L. TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res., 55: 1152-1159, 1995.
2. Gan, F., Gesell, M. S., Alousi, M., and Luk, G. D. Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry. J. Histochem. Cytochem., 41: 1185-1196, 1993.
3. Morimura, S., Suzuki, T., Hochi, S., Yuki, A., Nomura, K., Kitagawa, T., Nagatsu, I., Imagawa, M., and Muramatsu, M. Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat. Proc. Natl. Acad. Sci. USA, 90: 2065-2068, 1993.
4. Sue, S. R., Chari, R. S., Kong, F. M., Mills, J. J., Fine, R. L., Jirtle, R. L., and Meyers, W. C. Transforming growth factor-β receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg., 2: 171-178, 1995.
5. Osada, S., Takano, K., Nishihara, T., Suzuki, T., Muramatsu, M., and Imagawa, M. CCAAT/enhancer-binding proteins a and b interact with the silencer element in the promoter of glutathione S-transferase P gene during hepatocarcinogenesis. J. Biol. Chem., 270: 31288-31293, 1995.
6. Flodby, P., Liao, D. Z., Blanck, A., Xanthopoulos, K. G. H., and Hallstrom, I. P. Expression of the liver-enriched transcription factors C/EBPα, C/EBPβ, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol. Carcinog., 12: 103-109, 1995.
7. Cowan, K. H., Batist, G., Tulpule, A., Sinha, B. K., and Myers, C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. USA, 83: 9328-9332, 1986.
8. Peters, W. H. M., Boon, C. E. W., Roelofs, H. M. J., Wobbes, T., Magengast, F. M., and Kremers, P. G. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103: 448-455, 1992.
9. Pickett, C. B., and Lu, A. Y. H. Glutathione S-transferases: gene structure, regulation, and biological function. Annu. Rev. Biochem., 58: 743-764, 1989.
10. Rushmore, T. H., and Pickett, C. B. Glutathione S-transferases, structure, regulation, and therapeutic implications. J. Biol. Chem., 268: 11475-11478, 1993.
11. Kuo, M. T., Zhao, J. Y., Teeter, L. D., Ikeguchi, M., and Chisari, F. V. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell Growth & Differ., 3: 531-540, 1992.
12. Weinstein, R. S., Kuszak, J. R., Kluskens, L. F., and Coon, J. S. P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum. Pathol., 21: 34-48, 1990.
13. Juliano, R. L., and Ling, V. A surface glycoprotein modulating drug permeability and in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455: 152-162, 1976.
14. Riordan, J. R., and Ling, V. Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem., 254: 12701-12705, 1979.
15. Ng, W. F., Sarangi, F., Zastawny, R. L., Veinot-Drebot, L., and Ling, V. Identification of members of the P-glycoprotein multigene family. Mol. Cell. Biol., 9: 1224-1232, 1989.
16. 1 transcripts in multidrug-resistant Chinese hamster lung cells. J. Biol. Chem., 266: 4545-4555, 1991.
17. Gros, P., Ben Neriah, Y., Croop, J. M., and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature (Lond.), 323: 728-731, 1986.
18. Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., and Willingham, M. C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA, 85: 4486-4490, 1988.
19. Devault, A., and Gros, P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol., 10: 1652-1663, 1990.
20. Gros, P., Croop, J., and Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47: 371-380, 1986.
21. Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A., Pastan, I., and Gottesman, M. M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science (Washington DC), 236: 1120-1122, 1987.
22. Bradley, G., Sharma, R., Rajalakshmi, S., and Ling, V. P-glycoprotein expression during tumor progression in the rat liver. Cancer Res., 52: 5154-5161, 1992.
23. Volm, M., Zerban, H., Mattern, J., and Efferth, T. Overexpression of P-glycoprotein in rat hepatocellular carcinomas induced with N-nitrosomorpholine. Carcinogenesis (Lond.), 11: 169-172, 1990.
24. Fairchild, C. R., Ivy, S. P., Rushmore, T., Lee, G., Koo, P., Goldsmith, M. E., Myers, C. E., Farber, E., and Cowan, K. H. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 84: 7701-7705, 1987.
25. Moscow, J. A., and Cowan, K. H. Multidrug resistance. J. Natl. Cancer Inst., 80: 14-20, 1988.
26. Carr, B. I. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats. Cancer Res., 47: 5577-5583, 1987.
27. Mayol, X., Neal, G. E., Davies, R., Romero, A., and Domingo, J. Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. Carcinogenesis (Lond.), 13: 2381-2388, 1992.
28. Pinedo, H. M., and Giaccone, G. P-glycoprotein: a marker of cancer-cell behavior. N. Engl. J. Med., 333: 1417-1419, 1995.
29. Chan, H. S. L., DeBoer, G., Thorner, P. S., Haddad, G., Gallie, B. L., and Ling, V. Multidrug resistance: clinical opportunities in diagnosis and circumvention. Hematol.-Oncol. Clin. N. Am., 8: 383-410, 1994.
30. van Kalken, C. K., Pinedo, H. M., and Giaccone, G. Multidrug resistance from the clinical point of view. Eur. J. Cancer, 27: 1481-1486, 1991.
31. Messing, J. New M13 vectors for cloning. In: R. Wu, L. Grossman, and K. Moldave (eds.), pp. 20-78. New York: Academic Press, 1983.
32. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
33. Devereux, J., Haeberli, P., and Smithies, O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res., 12: 387-395, 1984.
34. Schuetz, J. D., Silverman, J. A., Thottassery, J. V., Furuya, K. N., and Schuetz, E. G. Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth & Differ., 6: 1321-1332, 1995.
35. Reuber, M. D. A transplantable bile-secreting hepatocellular carcinoma in the rat. J. Natl. Cancer Inst., 26: 891-897, 1961.
36. Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. J. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (Washington DC), 271: 1126-1128, 1996.
37. Xie, W., and Rothblum, L. I. Rapid, small-scale RNA isolation from tissue culture cells. BioTechniques, 11: 325-327, 1991.
38. Danielson, P. E., Forss-Petter, S., Brow, M. A., Calavetta, L., Douglass, J., Milner, R. J., and Sutcliffe, J. G. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7: 261-267, 1988.
39. Schuetz, J. D., and Schuetz, E. G. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth & Differ., 4: 31-40, 1993.
40. Lichtsteiner, S., and Schibler, U. A glycosylated liver-specific transcription factor stimulates transcription of the albumin gene. Cell, 57: 1179-1187, 1989.
41. Georges, E., Bradley, G., Gariepy, J., and Ling, V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 87: 152-156, 1990.
42. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
43. Laemmli, U. K. Clevage of structural proteins during the assembly of the head of bacteriophage. Nature (Lond.), 227: 680-685, 1970.
44. Schuetz, E. G., Furuya, K. N., and Schuetz, J. D. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J. Pharmacol. Exp. Ther., 275: 1011-1018, 1995.
45. Williams, G. M., Hirota, N., and Rice, J. M. The resistance of spontaneous mouse hepatocellular neoplasms to iron accumulation during rapid iron loading by parenteral administration and their transplantability. Am. J. Pathol., 94: 65-74, 1979.
46. Hirota, N., and Williams, G. M. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure. J. Natl. Cancer Inst., 63: 1257-1265, 1979.
47. Watanabe, K., and Williams, G. M. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst., 61: 1311-1314, 1978.
48. Williams, G. M., Klaiber, M., and Farber, E. Nature of early, appearing, carcinogen-induced liver lesions resistant to iron accumulation. J. Natl. Cancer Inst., 57: 157-165, 1996.
49. Hirota, N., and Williams, G. M. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation. Cancer Res., 42: 2298-2309, 1982.
50. Rice, G. C., Ling, V., and Schimke, R. T. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (Adriamycin) resistance. Proc. Natl. Acad. Sci. USA, 84: 9261-9264, 1987.
51. Haber, M., Reed, C., Kavallaris, M., Norris, M. D., and Stewart, B. W. Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate. J. Natl. Cancer Inst., 81: 1250-1254, 1989.
52. Norris, M. D., Haber, M., King, M., and Davey, R. A. Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression. Biochem. Biophys. Res. Commun., 165: 1435-1441, 1989.
53. Borst, P. Genetic mechanisms of drug resistance. Acta Oncol., 4: 87-105, 1991.
54. Lomri, N., Davern, T. J., Brown, R. S., Rahmaoui, C., Cavalieri, R. R., and Scharschmidt, B. F. Hepatocytes express an array of novel ATP-binding cassette (ABC) proteins with apparently diverse functions. Hepatology, 22: 312A, 1995.
55. Childs, S., Yeh, R. L., Georges, E., and Ling, V. Identification of a sister gene to P-glycoprotein. Cancer Res., 55: 2029-2034, 1995.
56. Furuya, K. N., Gebhardt, R., Schuetz, E. G., and Schuetz, J. D. Isolation of rat pgp3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim. Biophys. Acta, 1219: 636-644, 1994.
57. Kozak, M. How do eukaryotic ribosomes recognize the unique AUG initiator codon in messenger RNA? Biochem. Soc. Symp., 47: 113-128, 1982.
58. Ortiz, D. F., Kreppel, L., Speiser, D. M., Scheel, G., McDonald, G., and Ow, D. W. Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter. EMBO J., 11: 3491-3499, 1992.
59. Ortiz, D. F., Ruscitti, T., McCue, K. F., and Ow, D. W. Transport of metal-binding peptides by HMT1, a fission yeast ABC-type vacuolar membrane protein. J. Biol. Chem., 270: 4721-4728, 1995.
60. Koonin, E. V. Evidence for a family of archael ATPases. Science (Washington DC). 275: 1489-1490, 1997.
61. Koonin, E. V. A superfamily of ATPases with diverse functions containing either classical or deviant ATP-binding motif. J. Mol. Biol., 229: 1165-1174, 1993.
62. Higgins, C. F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol., 8: 67-113, 1992.
63. Strunnikov, A. V., Hogan, E., and Koshland, D. SMC2, a Saccharomyces cerevisiae gene essential for chromosome segregation and condensation, defines a subgroup within the SMC family. Genes Dev., 9: 587-599, 1995.
64. Mosser, J., Douar, A. M., Sarde, C. O., Kioschis, P., Feil, R., Moser, H., Poustka, A. M., Mandel, J. L., and Aubourg, P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature (Lond.), 361: 726-730, 1993.
65. Lombard-Platet, G., Savary, S., Sarde, C. O., Mandel, J. L., and Chimini, G. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern. Proc. Natl. Acad. Sci. USA, 93: 1265-1269, 1996.
66. Kamijo, K., Kamijo, T., Ueno, I., Osumi, T., and Hashimoto, T. Nucleotide sequence of the human 70 kDa peroxisomal membrane protein: a member of ATP-binding cassette transporters. Biochim. Biophys. Acta, 1129: 323-327, 1992.
67. Kamijo, K., Taketani, S., Yokota, S., Osumi, T., and Hashimoto, T. The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. J. Biol. Chem., 265: 4534-4540, 1990.
68. Ohashi, K., Tsutsumi, M., Tsujiuchi, T., Kobitsu, K., Okajima, E., Nakajima, Y., Nakano, H., Takahashi, M., Mori, Y., and Konishi, Y. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicine-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res., 56: 3474-3479, 1996.
69. Yang, C. L., Zhang, S. J., Toomey, N. L., Palmer, T. N., and Lee, M. Y. W. T. Induction of DNA polymerase activities in the regenerating rat liver. Biochemistry, 30: 7534-7541, 1991.
70. Lim, K., Park, H. C., Kim, K. Y., Lee, M. S., Kweon, G. R., Kwak, S. T., and Hwang, B. D. Regenerating liver-specific transacting factors of H2B histone gene are newly synthesized during liver regeneration. Biochem. Biophys. Res. Commun., 196: 1093-1100, 1993.
71. Hill, B. A., Brown, P. C., Preisegger, K. H., and Silverman, J. A. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis (Lond.), 17: 451-457, 1996.
72. Debenham, P. G., Kartner, N., Siminovitch, L., Riordan, J. R., and Ling, V. DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol. Cell. Biol., 2: 881-889, 1982.
73. Park, J. G., Lee, S. K., Hong, I. G., Kim, H. S., Lim, K. H., Choe, K. J., Kim, W. H., Kim, Y. I., Tsuruo, T., and Gottesman, M. M. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J. Natl. Cancer Inst., 86: 700-705, 1994.
74. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
75. Juranka, P. F., Zastawny, R. L., and Ling, V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J., 3: 2583-2592, 1989.
76. Nikaido, H. Maltose transport system of Escherichia coli: an ABC-type transporter. FEBS Lett., 346: 55-58, 1994.
77. Davidson, A. L., Laghaeian, S. S., and Mannering, D. E. The maltose transport system of Escherichia coli displays positive cooperativity in ATP hydrolysis. J. Biol. Chem., 277: 4858-4863, 1996.
78. Vazquez de Aldana, C. R., Marton, M. J., and Hinnebusch, A. G. GCN20, a novel ATP binding cassette protein, and GCN1 reside in a complex that mediates activation of the elF-2a kinase GCN2 in amino acid-starved cells. EMBO J., 14: 3184-3199, 1995.
79. Triana, F. J., Nierhaus, K. H., Ziehler, J., and Chakraburtty, K. Defining the function of EF-2 from low fungi. In: K. H. Nierhaus (ed.), The Translational Apparatus, pp. 75-89. New York: Elsevier, 1993.
80. Laconi, E., Denda, A., Rao, P. M., Rajalakshmi, S., Pani, P., and Sarma, D. S. R. Studies on liver tumor promotion in the rat by orotic acid: dose and minimum exposure time required for dietary orotic acid to promote hepatocarcinogenesis. Carcinogenesis (Lond.), 14: 1771-1775, 1993.
81. Fujimoto, Y., Ishizaka, Y., Tahira, T., Sone, H., Takahashi, H., Enomoto, K., Mori, M., Sugimura, T., and Nagao, M. Possible involvement of c-myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats. Mol. Carcinog., 4: 269-274, 1991.
82. Luciana, M-F., and Chimini, G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J., 15: 226-235, 1996.
83. Becq, F., Hamon, Y., Bajetto, A., Gola, M., Verrier, B., and Chimini, G. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J. Biol. Chem., 272: 2695-2699, 1997.
84. Czaja, M. J., Weiner, F. R., and Freedman, J. H. Amplification of the metallothionein-1 and metallothionein-2 genes in copper-resistant hepatoma cells. J. Cell. Physiol., 147: 434-438, 1991.
85. Suchy, B. K., Sarafoff, M., Kerler, R., and Rabes, H. M. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. Cancer Res., 49: 6781-6787, 1989.
86. Sugioka, Y., Fujii-Kuriyama, Y., Kitagawa, T., and Muramatsu, M. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis. Cancer Res., 45: 365-378, 1985.
87. Satoh, K., Kitahara, A., Soma, Y., Inaba, Y., Hatayama, I., and Sato, K. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA, 82: 3964-3968, 1985.